PolTREG

PolTREG

Poland - Gdańsk
Biotechnology
WebsiteLinkedInCareers Page

Focus: T-reg cell growth and reperfusion treatment

PolTREG is a life sciences company focused on T-reg cell growth and reperfusion treatment.

Metabolic DiseasesCell TherapyUnknown
Funding Stage
PUBLIC
Open Jobs
2

Pipeline & Clinical Trials

ex vivo expanded CD4+CD25+CD127- regulatory T cells
Presymptomatic Diabetes Type 1 (Stage 1)
Phase 2
Clinical Trials (1)
NCT06688331Treatment of Presymptomatic (Stage 1) Type 1 Diabetes Pediatric Patients With Treg Cell Preparations and Anti-CD20 Antibody
Phase 2

Open Jobs (2)

Biotechnology R&D Specialist

Unknown
Research and Development
2w ago

Production Biotechnologist

Unknown
Unknown
2w ago
Interview Prep Quick Facts
Founded: 2021
Portfolio: 1 clinical trial
Open Roles: 2 active jobs